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Abstract—Hypercapnia with hyperventilation during emer-
gence from anesthesia has been shown to reduce emergence time,
yet little is known about how the subsequent recovery in the post
anesthesia care unit (PACU) is affected. A mathematical model
has been developed to investigate how inhaled anesthetic agents
wash out of patients during recovery in order to demonstrate
any difference that hypercapnia and hyperventilation during
emergence might have on recovery.
I. INTRODUCTION
GENERAL anesthesia is composed of four phases: induc-tion, maintenance, emergence, and recovery. During the
induction phase, patients are placed in an anesthetized state
and intubated in preparation for surgery. Maintenance is the
continual administration and monitoring of anesthesia during
surgery. At the end of surgery, anesthesia is discontinued and
the patient is ventilated until they emerge from anesthesia, i.e.
their anesthetic level is such that they regain consciousness
and breathe spontaneously. Lastly, they are extubated and
transported to the PACU for recovery.
The durations of the emergence and recovery phases are
influenced by several factors: demographics, surgery length,
anesthetic type, hemodynamics, and ventilation. First, demo-
graphics, especially body type, can affect how anesthetic is
stored in the tissues of the body, e.g. fatty tissues store large
amounts of anesthetic compared to other tissue types, hence,
washout of the anesthetic can differ from patient to patient.
Second, surgery length directly affects how long tissues are
exposed to anesthetic agent. Third, anesthetic solubility is a
measure of how easily anesthetic dissolves in blood and differs
from agent to agent. For example, desflurane has a blood/gas
solubility coefficient of 0.45, sevoflurane 0.65, and isoflurane
1.40[1], [2]. As a result desflurane washes out faster than
sevoflurane, and sevoflurane washes out faster than isoflurane.
Lastly, hemodynamics and ventilation affect the way in which
gases, including anesthetics, enter, exit, and move throughout
the body.
The cardiovascular and respiratory systems work in tandem
to provide the necessary gas exchange for cellular metabolic
activity throughout the body. The respiratory system exchanges
O2 and CO2 between the atmosphere and blood; the circula-
tory system delivers the O2 to the cells throughout the body
and transports CO2, a byproduct of cellular respiration, from
the cells back to the lungs. When the concentration of CO2 in
the blood fluctuates, the cardiovascular and respiratory systems
are adjusted to compensate. For example, if the arterial partial
pressure of CO2 (PaCO2) rises—due to exercise or some kind
of strenuous activity—breathing rate and cardiac output will
increase and vasodilation will occur, causing an increasing in
blood flow and gas exchange in the lungs in order to flush the
body of excess CO2. When PaCO2 decreases, the opposite
occurs. In the operating room, this principle is frequently
taken advantage of in an effort to accelerate recovery from
anesthesia.
Induced hypercapnia, or elevated PaCO2, can be used to
accelerate a patient’s recovery by washing anesthetic vapors
from the body in the same way that excess CO2 is removed[3],
[4]. Hypercapnia during emergence has two important conse-
quences: it increases cerebral blood flow—helping to quickly
wash anesthetic from the brain; and it stimulates respiratory
drive[5], [6], [7]. Coupled with hyperventilation, a patient
is able to expel anesthetic vapors quickly and emerge from
anesthesia sooner with a stronger respiratory drive.
A device, developed in our lab, called the QED-100
(Anecare, Salt Lake City, UT), is used to accomplish this
task in many hospitals today[8]. The QED-100 incorporates
a rebreathing reservoir to induce hypercapnia and a charcoal
filter to capture expelled anesthetic gases. The QED-100 is
capable of reducing emergence time by approximately 55%[8],
[9], [10]. This result translates not only into a cost savings
from less time spent in the OR, but perhaps more importantly,
it produces a patient that can enter the PACU with less
anesthetic in their system and a stronger respiratory drive,
which in turn could lead to a faster, safer, and more satisfactory
recovery.
The incidence rate of complications in the OR and PACU
were estimated to be 1.3-5.1% and 23-24% respectively based
on a collection of over 42,000 patients[11], [12], [13]. PONV
and upper airway support were the most common events
encountered in the PACU, each accounting for roughly 1/3 of
all PACU complications (2/3 combined). One of the possible
reasons for the increased rate of complications in the PACU
may stem from the fact that as patients become more alert,
they become more aware of pain and often require additional
analgesic for pain management. Analgesics can react syner-
gistically with residual inhaled anesthetic still present in the
patient’s body, similar to how they react during the induction
phase of anesthesia, which can result in adverse clinical events
(e.g. respiratory depression or even loss of consciousness). Of
course, there are several other factors contributing to the like-
lyhood of complications in the PACU: surgery type, surgery
length, ASA physical status, and anesthetic technique[11],
[13]. However, aside from these factors, it stands to reason
that a patient entering the PACU with less anesthetic in their
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system may have a greater chance of avoiding complications.
While it has been shown that hypercapnia with hyperventila-
tion shortens emergence time by removing inhaled anesthetic
quickly, the actual levels of anesthetic that patients endure
during recovery are not well known. A study, already in
progress, has been designed to collect this data, which will
then be used to validate the model for anesthetic washout.
Lerou et al. described a mathematical model for the up-
take and distribution of inhaled anesthetic in a closed-circuit
system[1]. A similar model has been developed to simulate
not only uptake and distribution of anesthetic agent, but also
washout after the breathing circuit has been removed and the
patient is breathing spontaneously. Such a model will provide
estimates of agent concentration throughout the body that
would be difficult to attain through direct measurement—the
most important one being cerebral concentration.
In Gopalikrishnan’s disseration, he used a similar model to
determine cerebral concentrations of anesthetic agent during
emergence in order to estimate wake up times[14]. He was
able to show that hypercapnia with hyperventilation during
emergence quickly reduced the cerebral concentration of anes-
thetic agent, resulting in a faster wake up time. Likewise, an
analogous method will be implemented in order to determine
the cerebral concentration of anesthetic agent during key points
of recovery. Such a model will provide information that could
aid in the developement of a hypercapnia-inducing device for
the PACU or simply decision support for clinical staff.
II. METHODS
The mathematical model is based on a similar model
described and clinically validated by Lerou, et al. [1], [15].
It consists of 13 compartments that each represent a particular
tissue type or blood pool in the body. Each compartment
is fashioned from a basic model where a solute of known
concentration flows into a compartment of known volume,
having also an outlet with known flow (Figure 1(a)). The
ordinary differential equation describing such a scenario is
given Figure 1(b) where VB is the volume of the compartment,
Ci is the concentration of the incoming solute with flow rate
Qi, and CB is the concentration in the compartment and
outgoing solute with flow Qo.
From this basic model, a network of compartments was
constructed to simulate the flow of solute through the various
tissue groups and blood pools of the body. The solute in this
model is the inhaled anesthetic desflurane. As described in
Figure 2, the agent is taken in through the lungs, then into
the arterial blood pool—blood pools in the model introduce
a time delay to simulate circulation time. The arterial blood
distributes the anesthetic agent to the various tissue groups,
which then empty into the venous blood pool before returning
to the lungs.
A data set collected from patients during surgery and
recovery from anesthesia will be used to validate the model.
This step is currently underway. Following IRB approval,
44 patients undergoing eye muscle surgery will be randomly
divided in to two groups: a treatment group, which will
be hypercapnic and hypervenilated during emergence; and a
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Fig. 1. The basic model. (a) Diagram of the basic model showing a
compartment B, with known volume VB , and concentration of solute CB ,
also having incoming flow Qi with concentration Ci and out going flow
Qo with concentration CB . (b) Ordinary differential equation describing the
rate of change in concentration CB . (c) Simulink model that describes the
equation in (b).
control group. End tidal CO2 (EtCO2), end tidal and inspired
anesthetic agent concentration, and minute volume (MV) will
be recorded during surgery and recovery. This data will be
used to drive the model to simulate induction, maintenance,
and emergence phases of anesthesia. In this way, the model
will be preloaded with the correct amounts of agent so that
washout during recovery can be simulated accurately.
From the patient demographics, lean body weight (LBW )
will be estimated as
LBW = (1.1×BW − 128×BW
2
(100×H)2 (male)
LBW = (1.07×BW − 148×BW
2
(100×H)2 (female)
where BW is measured body weight and H is measured
height[16]. Subsequantly, several other physiological values
will be derived from LBW for the model: blood volume, tis-
sue volumes, cardiac output, alveolar space, etc[1]. A summary
of the variables, symbols, and their relationships are given in
Table I.
Using the basic model as a template (Figure 1(b)), the
equation describing the rate of change in agent concentration
for the alveolar space is
dCA
dt
=
(Des− CA)MV + (CV − Ca′)QL
VA
.
The first term in the numerator describes the net change in
concentration due to inhalation and exhalation of the gaseos
agent; the second term describes the change in terms of the
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TABLE I
SYMBOLS AND RELATIONSHIPS AMONG VARIABLES[1], [2]
Variable Description Relationship \Value
Demographics
A age (y) —
BW body weight (kg) —
H height (m) —
Fractional Concentrations
Ca agent leaving arterial pool
dCa
dt =
QCO(Ca′′−Ca)
Vbla
Ca′ agent in blood exposed to alveolar gas Ca′ = λbCA
Ca′′ agent entering arterial pool Ca′′ = Ca′ (1−Qfs) + CvQfs
CA agent in alveolar gas
dCA
dt =
(Des−CA)MV+(CV −Ca′ )QL
VA
Cat agent leaving adipose tissue
dCat
dt =
(Ca−Cat)Qat
Vatλat
Cb agent leaving brain tissue
dCb
dt =
(Ca−Cb)Qb
Vbλb
Cct agent leaving connective tissue
dCct
dt =
(Ca−Cct)Qct
Vctλct
Ch agent leaving heart tissue
dCh
dt =
(Ca−Ch)Qh
Vhλh
Ck agent leaving kidney tissue
dCk
dt =
(Ca−Ck)Qk
Vkλk
Cl agent leaving liver tissue
dCl
dt =
(Ca−Cl)Ql
Vlλl
Cm agent leaving muscle tissue
dCm
dt =
(Ca−Cm)Qm
Vmλm
Cvpa′ agent leaving venous pool: adipose tissue
dC
vpa′
dt =
(Cat−Cvpa′ )Qat
Vvpa
Cvpl agent entering venous pool: lean tissue Cvpl =
CmQm+CctQct
Qm+Qct
Cvpl′ agent leaving venous pool: lean tissue
dC
vpl′
dt =
(Cvpl−Cvpl′ )(Qm+Qct)
Vvpl
Cvpv agent entering venous pool: viscera Cvpv =
CbQb+ChQh+CkQk+ClQl
Qb+Qh+Qk+Ql
Cvpv′ agent leaving venous pool: viscera
dCvpv
dt =
(Cvpv−Cvpv′ )(Qb+Qh+Qk+Ql)
Vvpv
Cv agent leaving central venous pool
dCv
dt =
(C
v′−Cv)QCO
Vvpc
Cv′ agent entering central venous pool Cv′ =
C
vpv′ (Qb+Qh+Qk+Ql)+Cvpl′ (Qm+Qct)+Cvpa′Qat
QCO
Des agent in inspired air recorded concentration in Aim 1
Flows (L/min)
MV minute volume recorded MV in Aim 1
Qat flow through adipose tissue Qat = 0.05×QCO
Qb flow through brain tissue Qb = 0.16×QCO
QCO cardiac output QCO = 0.2× LBW
Qct flow through connective tissue Qct = 0.06×QCO
Qfs flow through pulmonary shunt 0.05
Qh flow through heart tissue Qh = 0.05×QCO
Qk flow through kidney tissue Qk = 0.25×QCO
Ql flow through liver tissue Ql = 0.3×QCO
Qm flow through muscle tissue Qm = 0.13×QCO
V olumes (L)
FRC function residual volume FRC = 0.65(2.34H + 0.009A− 1.090) [male]
FRC function residual volume FRC = 0.65(2.24H + 0.001A− 1) [female]
VA alveolar space VA = FRC + 0.8Vt + VLλbλL
Vat adipose tissue blood Vat = 0.15× LBW
Vb brain tissue blood Vb = 0.021× LBW
Vbl total blood Vbl = 0.07× LBW
Vbla arterial blood Vbla = 0.2× Vbl
Vblv venous blood Vblv = 0.8× Vbl
Vct connective tissue blood Vct = 0.26× LBW
Vd dead space Vd = 0.002× LBW
Vh heart tissue blood Vh = 0.004× LBW
Vk kidney tissue blood Vk = 0.004× LBW
VL lung tissue blood VL = 0.008× LBW
Vl liver tissue blood Vl = 0.057× LBW
Vm muscle tissue blood Vm = 0.426× LBW
Vvpa venous pool: adipose tissue Vvpa = 0.111× Vblv
Vvpc central venous pool Vvpc = 0.126× Vblv
Vvpl venous pool: lean tissue Vvpl = 0.364× Vblv
Vvpv venous pool: viscera Vvpv = 0.399× Vblv
Vt tidal volume mean of recorded TV in Aim 1
Partition Coefficients for Desflurane
λat tissue-blood in adipose tissue 29.0
λB blood-gas 0.45
λb tissue-blood in brain tissue 1.22
λct tissue-blood in connective tissue 1.40
λh tissue-blood in heart tissue 1.22
λk tissue-blood in kidney tissue 0.89
λL tissue-blood in lung tissue 1.30
λl tissue-blood in liver tissue 1.49
λm tissue-blood in muscle tissue 1.73
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Fig. 2. The 13 compartment model to simulate the uptake, distribution, and
washout of inhaled anesthetic agent. See Table I for variable descriptions and
relationships.
liquid agent in the blood stream using the appropriate blood-
gas partition coefficient for desflurane and noting that Ca′ =
λBCA. As blood leaves the lungs, it mixes with the blood from
the pulmonary shunt. This mixture enters the artial blood pool
with concentration
Ca′′ = Ca′(1−Qfs) + CvQfs.
For the arterial blood pool, the change in concentration is
dCa
dt
=
QCO(Ca′′ − Ca)
Vbla
,
which is then distributed to the major tissue compartments.
The tissue compartments can be described similarly as
dCt
dt
=
Qt(Ca − Ct)
Vtλt
where the subscript t denotes one of the seven tissue types.
The venous blood draining the brain, heart, kidney, and liver
(i.e. viscera) combines and enters a blood pool, called the
venous pool viscera, with concentration
Cvpv =
CbQb + ChQh+ CkQk + ClQl
Qb +Qh +Qk +Ql
.
The blood exiting the venous pool viscera then has concentra-
tion
dCvpv
dt
=
(Cvpv − Cvpv′)(Qb +Qh +Qk +Ql)
Vvpv
.
The next major tissue groups, muscle and connective tissue,
drain into a blood pool called the venous pool lean tissue. The
concentration entering this pool is
Cvpl =
CmQm + CctQct
Qm +Qct
and leaving
dCvpl′
dt
=
(Cvpl − Cvpl′)(Qm +Qct)
Vvpl
.
The last tissue group, adipose tissue, drains into the venous
pool adipose with concentration Cat. The concentration leav-
ing the pool is
dCat
dt
=
(Ca − Cat)Qat
Vatλat
.
Finally, the venous blood from the three venous pools
is collected into the central venous pool. Their combined
concentration is
Cv′ =
Cvpv′(Qb +Qh +Qk +Ql)
QCO
(1)
+
Cvpl′(Qm +Qct)
QCO
+
Cvpa′Qat
QCO
. (2)
The concentration leaving the central venous pool and return-
ing to the lungs is
dCv
dt
=
(Cv′ − Cv)QCO
Vvpc
,
concluding the family of equations that describe the model.
It has also been shown that PaCO2influences cerebral blood
flow, and so the following exponential relationship will be used
to alter cerebral blood flow as a function of PaCO2.
CBF = 4.29e0.0589EtCO2 ,
where CBF is cerebral blood flow in ml ·min−1 ·100g−1 and
PaCO2has been estimated using the easily measured EtCO2
(mmHg)[17].
The model will be evaluated in Simulink (Mathworks,
Natick, MA). Figure 1(c) shows the equivalent Simulink
model for the basic model described in the Figures 1(a) and
1(b). Besides its intuitive graphical interface for constructing
models, another useful feature in Simulink is its modular
approach to building complex models. The basic model in
Figure 1(c) can be encapsulated in its own block or module,
and then a series of these modules can be interconnected to
form the network that describes the model in Figure 2. The
equivalent Simulink model is shown in Figure 3.
III. RESULTS
The plot in Figure 4 shows a simulation of anesthetic con-
centrations during surgery, emergence, transport, and recovery
of a typical patient. The blue line shows the concentration
of inspired agent as recorded by the anesthesia machine.
The red and cyan show the simulated arterial and cerebral
concentrations. The purple and green lines show the measured
and simulated end tidal anesthetic concentration respectively .
At the beginning of surgery, the clinician usually gives a
high dose of agent concentration in order to quickly reach
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Fig. 4. Simulation of anesthetic concentration for a typical patient. Note the close approximation of the simulated end tidal anesthetic agent to the measured
one (purple and green lines respectively). The blue line shows the inspired concentration. The red and cyan lines show the arterial concentration and cerebral
concentration respectively. The cerebral concentration is modeled as a function of PaCO2. The bottom graph shows an expanded view of the washout period
during recovery.
the maintenance value of 6% end tidal agent concentration as
quickly as possible. Often this results in a brief overshoot, as
seen as the spike in concentration at the beginning of the case.
It can also be seen that the simulated end tidal concentration
nearly approximates the measured end tidal concentration.
This is most evident during the surgery and emergence periods.
During the transport period, when the patient is being discon-
nected from the anesthesia equipment and moved to the PACU,
the approximation differs more, but then seems to merge again
during recovery.
The bottom smaller graph shows an expanded view of the
recovery period. In this view it can be seen that the simulated
curve is slightly higher than the measured curve for nearly the
entire period.
When a paired t-test was performed on the end tidal data
for the surgery and emergence periods for 18 patients enrolled
in the study thus far, the difference between the simulated and
measured data was not significant, but during the transport
and recovery periods the difference was significant—despite
the apparent small difference shown in the expanded view.
IV. DISCUSSION
During the surgery and emergence periods, the patient data
(i.e. EtCO2, end tidal and inspired agent concentration, and
MV) is recorded at a sample frequency of 30 sec. During
transport period, no data is recorded because no monitors
can be connected while the patient is moved from the OR
to the PACU. Once the patient enters the PACU and is
situated the sample frequency is 100 Hz. However, for this
first set of simulations, data points taken every 5 min during
recovery were used. This was because at every 5 min interval
a calibration test was performed using a gas analyzer and
spirometer to calibrate the second monitor—a device used
to measure minute volume using only inductance through
elastic bands placed around the chest and abdomen (this is
so that patients were not required to wear an airtight mask
during recovery). The data available via the gas analyzer and
spirometer during the calibration periods was readily available
for use in the simulation. The higher resolution data, after
some work, can be made available for use in the simulation.
And after performing the t-test, it is apparent that the higher
resolution data should be used to see if it improves the model.
The two main driving forces behind washout are ventilation
and cardiac output. As was mentioned, during transport no data
is recorded; and as illustrated in Figure 4 by the measured
end tidal signal, data points in the minute volume signal
were linearly interpolated as an initial attempt to compensate
for the lack of data. A better interpolation method could
probably be devised, although it is not really known how
minute volume changes during transport. Cardiac output could
also be modified to improve the model.
In the original 1991 Lerou model, cardiac output was ap-
proximated as constant, estimated as a fraction of body weight,
which was also used in this model for simplicity sake[1].
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Fig. 3. Simulink model describing the uptake, distribution, and washout of
inhaled anesthetic.
However, since then studies have shown how cardiac output
can be influenced by PaCO2. In Gopalakrishnan’s dissertation,
he derived a relationship between cardiac output and PaCO2
based on measured data[14]. Implementing this relationship
might also improve washout.
V. CONCLUSIONS
While the model overall appears to simulate anesthetic con-
centrations well, especially during the surgery and emergence
periods, the discrepancies seen in the transport and recovery
periods are different enough to be significant and need to be
addressed before this model can be used to effectively explore
anesthetic washout during recovery.
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